Overview
The Collaboration Nation Event Agenda
Want to watch the pitches again? Missed the conference? You can listen and watch the presentations again when you want. Click on the red session titles and you'll be able to see the presentations and listen to the audio recordings. Why not follow the sessions with a copy of the 'Winners Directory' in your hand? It'll help you to make the right connection with the right presenter.
The Collaboration Nation - Exploiting Market Opportunities in Regenerative Medicine event is relevant to everyone who is interested in innovation and technology collaboration, funding, and commercialisation. With this in mind the event programme has been designed with plenty of opportunity to make new connections and to discuss future collaborations.
Agenda
Collaboration Nation - Exploiting Market Opportunities in Regenerative Medicine
0830 Registration opens
0930 Welcome & De-risking Innovation and the Future of Commercial Collaboration
Iain Gray, Chief Executive, Technology Strategy Board
0940 Feasibility Study Elevator Pitches - Session 1 (click session title to listen and watch presentation)
Winning project team members pitch their projects for 3-4 minutes highlighting who they are and what they are now looking for to take their project findings forward
- Aedstem
- Aqix Ltd
- Biocompatibles UK Ltd.
- Biopharma Technology
- Cell Medica
- ImmunoSolv
- Intercytex
- Neotherix
1020 Networking Break
1050 Feasibility Study Elevator Pitches - Session 2 (click session title to listen and watch presentation)
Winning project team members pitch their projects for 3-4 minutes highlighting who they are and what they are now looking for to take their project findings forward
- Orthox
- Pfizer
- Plasticell
- Progenteq
- Regentec
- ReNeuron
- ReNeuron
- Renovo
- RepRegen
- RepRegen
1130 Networking Break
1200 Feasibility Study Elevator Pitches - Session 3 (click session title to listen and watch presentation)
Winning project team members pitch their projects for 3-4 minutes highlighting who they are and what they are now looking for to take their project findings forward
- Livercyte
- Roslin Cells
- Smith & Nephew
- Stemcell Development Ltd
- The Automation Partnership
- The Ideas Studio
- Tigenix
- Tigenix
- Tissue Regenix
- Tissue Regenix
1240 Networking Lunch
Over 20 winning projects will be exhibiting. This is your opportunity to meet and understand more about the people behind the projects, and to discuss future collaborative activities.
1330 Regenerative Medicine: Value Systems and Business Models (click session title to listen and watch presentation)
Regenerative medicine companies operate in an emerging business sector in an international environment, where the delivery of regenerative medicine could take a number of different approaches as the products and services are developed. This session will provide a deep insight into where and how value will be created in the regenerative medicine value chain, and will highlight developments in business models that will enable businesses to best capture that value.
- Scottish Stem Cell Network Ltd
- Lonza Biologics PLC
- Biolatris Ltd
1430 Panel Session: Where is the innovation coming from in regenerative medicine and how can it be best commercialised? (click session title to listen and watch presentation)
In this panel session we'll be bringing together leading representatives from big pharma, academia, clinical services, the NHS and the SME base to identify the emerging opportunities in regenerative medicine, how to support them with a reduced direct R&D budget and how to use the supply chain to identify and exploit these new ideas.
Panel Chair: Anne Glover, Chief Executive, Amadeus Capital Partners Ltd, and Technology Strategy Board Governing Board Member
Panellists include: Ruth McKernan, Chief Scientific Officer, Pfizer Regenerative Medicine; Professor Roger Pedersen, Professor of Regenerative Medicine, Cambridge University; Marg Parton, CEO (Ret'd), NHS Technology Adoption Centre; Alan Lamont, Director of Science & Technology Alliances, Astra Zeneca
1530 The Technology Strategy Board - What Next? (click session title to listen and watch presentation)
Zahid Latif, Head of Healthcare, Technology Strategy Board
David Bott, Director of Innovation Programmes, Technology Strategy Board
1600 Networking reception